Kay Limoli

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Christos J. Petropoulos, Neil Parkin, Kay Limoli et al. · Antimicrobial Agents and Chemotherapy · 2000 · 648 citations · Full text

Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism

Jeannette M. Whitcomb, Wei Huang, Signe Fransen et al. · Antimicrobial Agents and Chemotherapy · 2006 · 354 citations · Full text

Primary Immunodeficiency, Neurovirology, Human Retrovirus +14

Amino Acid Substitutions at Position 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Increase Susceptibility to Delavirdine and Impair Virus Replication

Wei Huang, Andrea V. Gamarnik, Kay Limoli et al. · Journal of Virology · 2002 · 102 citations · Full text

Viral Replication, Position 190, Immunology +18

Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors

Richard J. Colonno, Alexandra Thiry, Kay Limoli et al. · Antimicrobial Agents and Chemotherapy · 2003 · 98 citations · Full text

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1

Jeannette M. Whitcomb, Wei Huang, Kay Limoli et al. · AIDS · 2002 · 95 citations